Common use of Quality Measure Reporting Clause in Contracts

Quality Measure Reporting. A. Except as set forth in Section 9.03.B, the DCE shall completely and accurately report quality measures for each Performance Year and shall require its DC Participant Providers to cooperate in quality measure reporting. Complete reporting means that the DCE meets all of the reporting requirements including timely reporting of the requested data for all measures. B. The DCE shall not report quality measures data on behalf of its DC Participant Providers for a Performance Year if the DCE provides notice of termination of the Agreement Performance Period pursuant to Section 17.03 by the Termination Without Liability Date for the Performance Year, and the termination is effective no later than 30 Days after such Termination Without Liability Date. C. CMS shall use the following sources for quality reporting: 1. Medicare claims submitted for items and services furnished to DC Beneficiaries; 2. Any other relevant data shared between the DCE and CMS pursuant to the Agreement; and 3. For Performance Year 2022 and subsequent Performance Years, results from the Consumer Assessment of Healthcare Providers and Systems (CAHPS®)1 or other patient experience surveys. D. The DCE is responsible for procuring a CMS-approved vendor to conduct the CAHPS or other patient experience surveys. The DCE is responsible for paying for the surveys and for ensuring that the survey results are transmitted to CMS by a date and in a form and manner established by CMS.

Quality Measure Reporting. A. Except as set forth in Section 9.03.B, the DCE ACO shall completely and accurately report the quality measures specified in Appendix D for each Performance Year and shall require its DC Participant Providers to cooperate in quality measure reporting. Complete reporting means that the DCE ACO meets all of the reporting requirements requirements, including timely reporting of the requested data for all measures. B. The DCE ACO shall not report quality measures data on behalf of its DC Participant Providers for a Performance Year if the DCE ACO provides notice of termination of the Agreement Performance Period pursuant to Section 17.03 by the Termination Without Liability Date for the Performance Year, and the termination is effective no later than 30 Days after such Termination Without Liability Date. C. CMS shall use the following sources for quality reporting: 1. Medicare claims submitted for items and services furnished to DC REACH Beneficiaries; 2. Any other relevant data shared between the DCE ACO and CMS pursuant to the Agreement; and 3. For Performance Year 2022 and subsequent Performance Years, results from the Consumer Assessment of Healthcare Providers and Systems (CAHPS®)1 or other patient experience surveys. D. The DCE is responsible for procuring ACO shall procure a CMS-approved vendor to conduct the CAHPS or other patient experience surveys. The DCE is responsible for paying ACO shall pay for the surveys and for ensuring ensure that the survey results are transmitted to CMS by a date and in a form and manner established by CMS.

Quality Measure Reporting. A. Except as set forth in Section 9.03.B, the DCE shall completely and accurately report quality measures for each Performance Year and shall require its DC Participant Providers to cooperate in quality measure reporting. Complete reporting means that the DCE meets all of the reporting requirements including timely reporting of the requested data for all measures. B. The DCE shall not report quality measures data on behalf of its DC Participant Providers for a Performance Year if the DCE provides notice of termination of the Agreement Performance Period pursuant to Section 17.03 by the Termination Without Liability Date for the Performance Year, and the termination is effective no later than 30 Days after such Termination Without Liability Date. C. CMS shall use the following sources for quality reporting: 1. Medicare claims submitted for items and services furnished to DC Beneficiaries; 2. Any other relevant data shared between the DCE and CMS pursuant to the Agreement; and 3. For Performance Year 2022 and subsequent Performance Years, results from the Consumer Assessment of Healthcare Providers and Systems (CAHPS®)1 or other patient experience surveys. 1 CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality. D. The For Performance Year 2022 and each subsequent Performance Year, the DCE is responsible for procuring a CMS-approved vendor to conduct the CAHPS or other patient experience surveys. The DCE is responsible for paying for the surveys and for ensuring that the survey results are transmitted to CMS by a date and in a form and manner established by CMS.